Expression of iron homeostasis proteins in sickle cell disease and β-thalassemia

被引:0
|
作者
Hagar, W
Jenkins, Z
Johansson, H
Vichinsky, EP
Theil, EC
机构
[1] Childrens Hosp Oakland, Res Inst, Dept Hematol Oncol, Oakland, CA 94609 USA
[2] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
1367
引用
收藏
页码:243A / 243A
页数:1
相关论文
共 50 条
  • [31] Pregnancy in Thalassemia and Sickle Cell Disease: The Experience of an Italian Thalassemia Center
    Sorrentino, Francesco
    Maffei, Laura
    Caprari, Patrizia
    Cassetta, Rita
    Dell'Anna, Donatella
    Materazzi, Stefano
    Risoluti, Roberta
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [32] Leukocyte apoptosis and inflammation in iron-overloaded patients with sickle cell disease or β-thalassemia:: A mechanism for increased stroke and disease severity in sickle cell disease.
    Walter, Patrick B.
    Killilea, David W.
    Fung, Ellen B.
    Lui, Annie
    Madden, Jacqueline
    Porter, John
    Evans, Patricia
    Ames, Bruce N.
    Vichinsky, Elliott
    Harmatz, Paul
    BLOOD, 2006, 108 (11) : 363A - 363A
  • [33] Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases
    Wood, John C.
    Ghugre, Nilesh
    HEMOGLOBIN, 2008, 32 (1-2) : 85 - 96
  • [34] Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease
    Mangaonkar, Abhishek A.
    Thawer, Fahim
    Son, James
    Ajebo, Germame
    Xu, Hongyan
    Barrett, Nadine J.
    Wells, Leigh G.
    Bowman, Latanya
    Clair, Betsy
    Patel, Niren
    Bora, Pritam
    Jung, Grace
    Nemeth, Elizabeta
    Kutlar, Abdullah
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (06) : 1204 - 1209
  • [35] Sickle cell disease and thalassemia: examples of a Darwinian approach to disease
    Charmot, G
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 2001, 94 (02): : 75 - 76
  • [36] A Systematic Review of the Effect of Iron Chelation Therapy on Survival in Patients with Sickle Cell Disease and ß-Thalassemia
    Ballas, Samir K.
    Duong, Vu H.
    Deveaux, Michelle
    Zeidan, Amer M.
    BLOOD, 2017, 130
  • [37] Adherence to Iron Chelation Therapy with Deferasirox Formulations among Patients with Sickle Cell Disease and β-thalassemia
    Oyedeji, Charity, I
    Crawford, Regina D.
    Shah, Nirmish
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2021, 113 (02) : 170 - 176
  • [38] Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia.
    Fung, Ellen B.
    Harmatz, Paul
    Milet, Meredith
    Vichinsky, Elliott
    BLOOD, 2006, 108 (11) : 140A - 140A
  • [39] The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic review
    Ballas, Samir K.
    Zeidan, Amer M.
    Duong, Vu H.
    DeVeaux, Michelle
    Heeney, Matthew M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 943 - 952
  • [40] Utility of Holter electrocardiogram monitoring in iron over loaded β thalassemia and sickle cell disease.
    Qureshi, N
    Avasarala, K
    Singer, ST
    Foote, D
    Hackney-Stephens, E
    Hagar, R
    Vichinsky, EP
    BLOOD, 2004, 104 (11) : 33B - 33B